# Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"

> **NCT05103644** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Beni-Suef University** · enrollment: 60 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Atorvastatin 80mg
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT05103644
- **Lead sponsor:** Beni-Suef University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-30
- **Primary completion:** 2023-12-30
- **Final completion:** 2024-12-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05103644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05103644, "Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05103644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*